Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Condylomata Acuminata × Vaccination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 2 Warts 1 Recurrence 1 Pneumonia, Pneumococcal 1 Pneumococcal Infections 1 Neoplasms 1 Multiple Myeloma 1 Immunologic Deficiency Syndromes 1 Hematologic Neoplasms 1 Febrile Neutropenia 1 Esophageal Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Condylomata Acuminata 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14 Vaccines, Synthetic 10 Papillomavirus Vaccines 6 Vaccines 5 Imiquimod 4 Trichloroacetic Acid 3 Gels 3 green tea extract polyphenone E 2 Podophyllin 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 Ethanol 2 Duration of Therapy 2 Cantharidin 2 ranpirnase 1 polyphenon E 1 nanocurcumin 1 hecolin 1 berdazimer sodium 1 Zinc 1 Viusid 1 Vaccination 1 VP-102 1 Therapies, Investigational 1 Tea 1 PRA1 protein, Candida albicans 1 Omiganan 1 Ointments 1 Measles-Mumps-Rubella Vaccine 1 Lasers, Gas 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03296397 2018-02-27

CONDYVAC

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown

Condylomata Acuminata, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡